drugset / Trial / NCT03553173

So-Lo-Mo Intervention Applied to the Smoking Cessation Process

NCT03553173

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized open-label parallel-group trial. 240 subjects will be recruited during 8 months and a 12 months follow-up will be carried out for each one of them. The sample will split in two groups: control group (n=120) who will receive usual psycho-pharmacological therapy and the intervention group (n=120) who will receive usual therapy plus So-Lo-Mo app.

Timeline

Start
2016-10-24
Primary completion
2018-10-24
Completion
2018-10-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg
Subject Varenicline Small molecule 0.5 mg
Subject Varenicline Small molecule 1 mg

Indications

No indication recorded.